Rajesh Shashikant Dalal

Biogenomics Ltd. is a leading biopharmaceutical company based in Mumbai, IN that focuses on diabetes and cancer care. The company's unique products in the pipeline include Next-Gen diabetic medications (Long and fast-acting Insulin) and Cancer Immunotherapy. The Indian company provides advanced cGMP production, manufacturing, research, and development facilities, and are WHO GMP certified with advanced formulation capabilities. Biogenomics is fully equipped and DSIR approved with more than 200 total employees, including 70 scientists, with a vision of adaptive innovations. The company was founded by Sanjay Sonar and the CEO is R. M. Parakh.

Biogenomics Ltd. is a leading biopharmaceutical company based in Mumbai, IN that focuses on diabetes and cancer care. The company's unique products in the pipeline include Next-Gen diabetic medications (Long and fast-acting Insulin) and Cancer Immunotherapy. The Indian company provides advanced cGMP production, manufacturing, research, and development facilities, and are WHO GMP certified with advanced formulation capabilities. Biogenomics is fully equipped and DSIR approved with more than 200 total employees, including 70 scientists, with a vision of adaptive innovations. The company was founded by Sanjay Sonar and the CEO is R. M. Parakh.

Biogenomics Ltd. is a leading biopharmaceutical company based in Mumbai, IN that focuses on diabetes and cancer care. The company's unique products in the pipeline include Next-Gen diabetic medications (Long and fast-acting Insulin) and Cancer Immunotherapy. The Indian company provides advanced cGMP production, manufacturing, research, and development facilities, and are WHO GMP certified with advanced formulation capabilities. Biogenomics is fully equipped and DSIR approved with more than 200 total employees, including 70 scientists, with a vision of adaptive innovations. The company was founded by Sanjay Sonar and the CEO is R. M. Parakh.

Biogenomics Ltd. is a leading biopharmaceutical company based in Mumbai, IN that focuses on diabetes and cancer care. The company's unique products in the pipeline include Next-Gen diabetic medications (Long and fast-acting Insulin) and Cancer Immunotherapy. The Indian company provides advanced cGMP production, manufacturing, research, and development facilities, and are WHO GMP certified with advanced formulation capabilities. Biogenomics is fully equipped and DSIR approved with more than 200 total employees, including 70 scientists, with a vision of adaptive innovations. The company was founded by Sanjay Sonar and the CEO is R. M. Parakh.

Ascent Meditech Ltd. provides orthopedic soft goods, bandages, mobility aids and healthcare products. It offers wide range of products for re-habilitation from various Musculoskeletal disorders from cervical, knee, chest, back, ankle and foot. It also provides bandages for home and hospital use and products such as Orthopaedic Heat Belts, Cool packs, Cool Eyes & Hot n Cold Masks. The company was founded on June 12, 2012 and is headquartered in Mumbai, India.

Ascent Meditech Ltd. provides orthopedic soft goods, bandages, mobility aids and healthcare products. It offers wide range of products for re-habilitation from various Musculoskeletal disorders from cervical, knee, chest, back, ankle and foot. It also provides bandages for home and hospital use and products such as Orthopaedic Heat Belts, Cool packs, Cool Eyes & Hot n Cold Masks. The company was founded on June 12, 2012 and is headquartered in Mumbai, India.

Ascent Meditech Ltd. provides orthopedic soft goods, bandages, mobility aids and healthcare products. It offers wide range of products for re-habilitation from various Musculoskeletal disorders from cervical, knee, chest, back, ankle and foot. It also provides bandages for home and hospital use and products such as Orthopaedic Heat Belts, Cool packs, Cool Eyes & Hot n Cold Masks. The company was founded on June 12, 2012 and is headquartered in Mumbai, India.

Ascent Meditech Ltd. provides orthopedic soft goods, bandages, mobility aids and healthcare products. It offers wide range of products for re-habilitation from various Musculoskeletal disorders from cervical, knee, chest, back, ankle and foot. It also provides bandages for home and hospital use and products such as Orthopaedic Heat Belts, Cool packs, Cool Eyes & Hot n Cold Masks. The company was founded on June 12, 2012 and is headquartered in Mumbai, India.

Biogenomics Ltd. is a leading biopharmaceutical company based in Mumbai, IN that focuses on diabetes and cancer care. The company's unique products in the pipeline include Next-Gen diabetic medications (Long and fast-acting Insulin) and Cancer Immunotherapy. The Indian company provides advanced cGMP production, manufacturing, research, and development facilities, and are WHO GMP certified with advanced formulation capabilities. Biogenomics is fully equipped and DSIR approved with more than 200 total employees, including 70 scientists, with a vision of adaptive innovations. The company was founded by Sanjay Sonar and the CEO is R. M. Parakh.

Biogenomics Ltd. is a leading biopharmaceutical company based in Mumbai, IN that focuses on diabetes and cancer care. The company's unique products in the pipeline include Next-Gen diabetic medications (Long and fast-acting Insulin) and Cancer Immunotherapy. The Indian company provides advanced cGMP production, manufacturing, research, and development facilities, and are WHO GMP certified with advanced formulation capabilities. Biogenomics is fully equipped and DSIR approved with more than 200 total employees, including 70 scientists, with a vision of adaptive innovations. The company was founded by Sanjay Sonar and the CEO is R. M. Parakh.

Biogenomics Ltd. is a leading biopharmaceutical company based in Mumbai, IN that focuses on diabetes and cancer care. The company's unique products in the pipeline include Next-Gen diabetic medications (Long and fast-acting Insulin) and Cancer Immunotherapy. The Indian company provides advanced cGMP production, manufacturing, research, and development facilities, and are WHO GMP certified with advanced formulation capabilities. Biogenomics is fully equipped and DSIR approved with more than 200 total employees, including 70 scientists, with a vision of adaptive innovations. The company was founded by Sanjay Sonar and the CEO is R. M. Parakh.